Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, it is possible to put weight on while taking Mounjaro, though it runs against the grain of what the medicine is designed to do. Most people lose weight on tirzepatide, sometimes quite significantly, but a minority do gain weight or plateau during treatment. Understanding why that happens (and what to do about it) is what this page covers. Mounjaro is a prescription-only medicine; a clinician assesses whether it is right for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is not a myth. While the SURMOUNT-1 trial found tirzepatide produced average body-weight reductions of around 20–21% at the highest dose over 72 weeks, that is an average across thousands of participants, and averages hide the full picture. A smaller group within any large trial does not respond in the expected direction, at least not immediately. Mounjaro's effect on weight is real and well-documented, but it is not uniform.
The most common scenarios where someone puts weight on with Mounjaro are: staying on the starter dose for longer than intended, missing doses, continuing habits that deliver more calories than the reduced appetite is saving, or experiencing weight gain driven by another cause that the medicine cannot fully counteract at early doses. None of these mean the treatment has failed, but all of them are worth unpicking.
It also matters what the scales are measuring. Early in treatment, the medicine slows gastric emptying, which can shift how full the gut is at any given time. A small, temporary rise on the scales in the first week or two does not always represent fat gain. That said, if the number is climbing steadily across several weeks, that is a different conversation.
The 2.5 mg starting dose exists to let your body adjust to tirzepatide without being floored by nausea. It is not where the medicine's appetite effects are strongest. Some people find that nausea at even the lowest dose makes food unappealing, genuinely suppressing intake. Others feel little effect on hunger at all and continue eating at much the same level as before, or they switch to softer, more calorie-dense foods to manage GI discomfort, which can quietly push calories up.
The NHS patient information for tirzepatide notes that the medicine is prescribed alongside a reduced-calorie diet and increased physical activity, it is not designed to do the whole job on its own. When those lifestyle elements slip, particularly at doses where appetite suppression is still mild, weight can creep up rather than down.
Your prescriber will typically increase the dose in four-week steps. As the dose climbs, most people notice a clearer reduction in appetite and food noise. If you are concerned that you are putting weight on rather than losing it while waiting for the next dose step, there is more detail on the specific causes worth reading before your next review.
Several, and some of them have nothing to do with the medicine itself. Corticosteroids, certain antidepressants, antipsychotics and hormonal contraceptives can all cause independent weight gain. An underactive thyroid, polycystic ovary syndrome and insulin resistance can similarly work against weight loss. If any of these are in play (or newly introduced) Mounjaro may slow the gain but not reverse it at lower doses.
Significant emotional stress or disrupted sleep consistently drives weight gain through hormonal pathways that appetite medicines do not fully address. It is also worth noting that muscle weighs more than fat: if you have started strength training alongside treatment, a modest scale increase can reflect muscle gain rather than fat accumulation, which is actually a good sign for long-term body composition.
The MHRA's guidance on GLP-1 medicines for weight loss, published on GOV.UK, is clear that these medicines are not assessed for quick or effortless weight loss. They work best as part of a sustained approach. If you are putting on weight with Mounjaro and cannot identify an obvious reason, tell your prescriber, they can look at what else might be driving it, including whether any other health conditions are involved, so it is worth reading about how Mounjaro interacts with conditions like shingles to understand the broader picture. You can also find an overview of how tirzepatide works as a medicine if the mechanism is still unclear.
First, rule out the dose-timing factor. A delayed or missed dose is one of the more overlooked reasons why weight can go up unexpectedly, even a few days' gap can blunt the medicine's effect noticeably. Keep the pen in a consistent spot in the fridge so it stays part of your weekly routine rather than something you have to hunt for on injection day.
Second, look honestly at what has changed. Have calories crept up through softer foods chosen for GI comfort? Has activity dropped? Has a new medicine been added? These are the questions your prescriber will ask anyway, so thinking them through in advance makes the conversation more productive.
Third, do not wait it out in silence. Mounjaro is a prescription-only medicine reviewed clinically before every supply at a regulated pharmacy. At nume, your clinical team reviews your case before each repeat, that is precisely the right moment to flag that the scales are moving in the wrong direction. Adjustments to dose timing, the support around the medicine, or investigation of an underlying cause all happen through that conversation, not around it.
If you are also weighing up what treatment might cost and how pricing compares across providers, our Mounjaro pricing page lays that out clearly. And if you want a broader view of options, our weight-loss treatment overview covers what is licensed in the UK and how the different medicines compare. The NHS patient information for tirzepatide on the NHS website also covers what to do if treatment is not working as expected.
If after reading all of this you want to talk to a prescriber about whether Mounjaro is right for you, or why it does not seem to be working as you hoped, you can start your free consultation with our team today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.